SCHEMBL29205093

SCHEMBL29205093

COc1ccc(-c2cccc3cnc(Nc4cccc(C(=O)CN5CCNCC5)c4)nc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.44
▸ MAPK10 P53779 2/20 0.43
▸ RIPK2 O43353 1/20 0.43
▸ FGFR2 P21802 1/20 0.42
▸ SCN9A Q15858 2/20 0.41
▸ BMPR2 Q13873 1/20 0.41
▸ CCNE2 O96020 1/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ JUN P05412 1/20 0.41
▸ ACP1 P24666 1/20 0.41
▸ MET P08581 1/20 0.40
▸ ALK Q9UM73 1/20 0.40
▸ TTK P33981 3/20 0.40
▸ IKBKB O14920 1/20 0.40
▸ CHUK O15111 1/20 0.40
▸ SYK P43405 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28696345 0.83 ACP1 (0.47) EGFRMAPK10RIPK2FGFR2BMPR2
SCHEMBL18377063 0.81 TTK (0.51) MAPK10RIPK2BMPR2CDK4CCND1
SCHEMBL29368477 0.81 TTK (0.51) MAPK10RIPK2BMPR2CDK4CCND1
SCHEMBL18376773 0.80 PTK2 (0.55) FGFR2SCN9A
SCHEMBL29371922 0.78 ALDH1A1 (0.52) MAPK10JUNMAPT
SCHEMBL28696348 0.78 ALDH1A1 (0.52) MAPK10JUNMAPT
SCHEMBL18377040 0.76 PIK3CG (0.60) EGFRMAPK10RIPK2CDK2JUN
SCHEMBL29370809 0.76 PIK3CG (0.60) EGFRMAPK10RIPK2CDK2JUN
SCHEMBL5168948 0.75 ALDH1A1 (0.49) IKBKBCHUKSYK
SCHEMBL18376777 0.75 EGFR (0.60) EGFRCDK4CCND1CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
Send feedback